Pacgen Life Science Corp (PBS)

TSXV
0.0300
0.0000(0.00%)
  • Volume:
    0
  • Bid/Ask:
    0.0200/0.0300
  • Day's Range:
    0.0300 - 0.0300
Trading near 52-week High

Pacgen Life Science has hit the highest price it has traded for over the last year (52 week period). This is a technical indicator that can be used to analyze the stock's current value and predict future price movement.

1 / 2

PBS Overview

Prev. Close
0.03
Day's Range
0.03-0.03
Revenue
-
Open
0.03
52 wk Range
0.03-0.03
EPS
-0.01
Volume
0
Market Cap
1.94M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
12,744
P/E Ratio
-
Beta
3.02
1-Year Change
0%
Shares Outstanding
64,815,969
Next Earnings Date
-
What is your sentiment on Pacgen Life Science?
or
Market is currently closed. Voting is open during market hours.

Pacgen Life Science Corp News

Pacgen Life Science Corp Analysis

Pacgen Life Science Corp Company Profile

Pacgen Life Science Corp Company Profile

Industry
Distributors
Employees
10
Market
Canada
  • Type:Equity
  • Market:Canada
  • ISIN:CA69374M1041
  • CUSIP:69374M104

Pacgen Life Science Corporation, a life sciences company, focuses on building a commercial platform to market and distribute consumer health products in North America. It offers oral care products, such as mouth rinse solutions, mouth sprays, and toothpastes for adults and children; skin care products, including natural-organic personal care products, such as natural therapeutic skincare, sensitive skincare, and children skincare, as well as other specialty personal care products; and health supplement products comprising natural nutritional supplement products for children. Pacgen Life Science Corporation through a sublicense arrangement with General Biologicals Corporation markets its products under the trade name of P113+ in Asia. The company was formerly known as Pacgen Biopharmaceuticals Corporation and changed its name to Pacgen Life Science Corporation in May 2012. Pacgen Life Science Corporation was founded in 2004 and is headquartered in Vancouver, Canada. As of September 30, 2020, Pacgen Life Science Corporation operates as a subsidiary of General Biologicals Corporation.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving Averages
Technical Indicators
Summary